We have located links that may give you full text access.
Multiple HIV-1 subtypes were found circulating in Shijingshan District of Beijing, China.
AIDS Research and Human Retroviruses 2019 January 26
There has been a rapid increasing of HIV cases in the men who have sex with men (MSM) population in China. This study enrolled 223 HIV-1 sero-positive drug-na?ve patients from Shijingshan district in Beijing MSM population. The full-length gag, pol, and partial env gene sequences were amplified. Subsequently, genetic characterization and transmission of drug-resistance of HIV-1 were examined. Many stains, including CRF01_AE (48.25%), CRF07_BC (31.47%), subtype B (4.9%), 0107 (6.29%), 01B (1.40%), 01BC (2.10%), 55_01B (1.40%), 59_01B (0.70%), 65_cpx (2.10%), 79_0107 (0.70%) and A (0.70%) were identified. Among 106 samples that harbor full-length PR region, 10 (9.43%) strains showed mutation that is known to be associated with drug resistance to any class of protease inhibitors (PI). Among 59 samples that harbor full-length RT region, none contained any mutations to nucleoside reverse transcriptase inhibitors (NRTIs), and 4 cases (6.78%) showed drug-resistance mutations to non-nucleoside reverse transcriptase inhibitors (NNRTIs). Among 58 samples that harbor full-length IN region, 1 stains (1.72%) contained mutation that is known to be associated with drug resistance to any class of Integrase strand transfer inhibitors (INIs).Our results provided detailed genetic data and would be helpful for understanding the background of HIV-1 transmission among local MSM populations.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app